Article
Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.
PloS one - 1 Jan 2011
Mankoo Parminder K, Shen Ronglai, Schultz Nikolaus, Levine Douglas A, Sander Chris
Abstract excerpt
BACKGROUND: Serous ovarian cancer (SeOvCa) is an aggressive disease with differential and often inadequate therapeutic outcome after standard treatment. The Cancer Genome Atlas (TCGA) has provided rich molecular and genetic profiles from hundreds of primary surgical samples. These profiles confirm mutations of TP53 in ~100% of patients and an extraordinarily complex profile of DNA copy number changes with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
